(45) incorporated IHC biomarkers (ER, PR, and HER2 expression), clinical manifestation (inflammatory breast cancer [IBC] vs. non-IBC), and NAT regimen. The gene discussed is ERBB2; the disease is inflammatory breast carcinoma.